As we work in this value-based economy, we need strong economic models that show the financial impact of osteoporosis on patients, healthcare systems, and the government (many of our patients are on Medicare or are dual eligibles on Medicare and Medicaid). When we began this work, we knew we needed a partner with technical expertise who was also objective and trusted.
Read MoreNOF on behalf of the NBHPI has submitted comments to CMS and HHS regarding proposed rules that could impact osteoporosis patients access to testing and treatment.
Read MoreCompelling research points to the substantial benefits of increasing access to screening for osteoporosis.
Read MoreThe National Osteoporosis Foundation (NOF) is pleased to submit its comments to the above referenced Proposed Rule promulgated by the Department of Health and Human Services (HHS) to remove Anti-Kickback Statute (AKS) safe harbor protection for manufacturer prescription drug rebates in connection with…
Read MoreThe National Osteoporosis Foundation (NOF) is pleased to submit its comments to the above- referenced proposed rule entitled “Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out of Pocket Expenses (the Proposed Rule). We previously responded…
Read MoreNOF understands that the IPI Model would leverage both the waiver authority of the Center for Medicare and Medicaid Innovation (CMMI) and the statutory provisions authorizing a…
Read More
